Evotec AG increases its revenue guidance

15-Sep-2015 - Germany

Evotec AG announced that it increases its financial guidance for the current year. The Company now expects Group revenues excluding milestones, upfronts and licences to increase by approx. 45% (previously: more than 35%) compared to last year (2014: EUR 73.4 m) mainly as a result of Evotec's strong business performance of EVT Execute, accelerated growth in the EVT Innovate business and a positive outlook for the remainder of the year.

All other elements of the Company's financial guidance as of 12 May 2015 are confirmed.

Evotec's Group EBITDA before changes in contingent considerations is expected to be positive.
Evotec expects research and development (R&D) expenses to grow to EUR 15 m - EUR 20 m in 2015.
Evotec will continue to invest in its technology platforms and capacities in order to drive its long-term growth strategy. It is therefore planned that up to EUR 10 m will be invested in further capacity increases and the upgrade of Evotec's technological capabilities. Liquidity is expected to be well in excess of EUR 100 m at 31 December 2015. This forecast excludes any potential cash outflow from M&A or similar transactions.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances